BSI member Professor Michael Dustin, explains, «While an overwhelming T - cell response might on the face of it sound effective, it brings risks
of immunopathology, where an over-active immune system destroys healthy human tissue, not just the invading disease - causing pathogen.
The vaccines were evaluated for immunogenicity and efficacy; however, because of the previous report
of immunopathology on challenge of ferrets and nonhuman primates that had been vaccinated with a whole virus adjuvanted vaccine and mice that had been vaccinated with a VLP vaccine, the primary orientation was to assess for immunopathology among animals in relation to type of vaccine, dosage, serum antibody responses, and virus infection.
Additionally, a more intense study for virus replication including quantitative RT - PCR assays might have confirmed the probability that virus replication is required for induction
of the immunopathology after vaccination.
Finally, a number of other studies of vaccines in animal model systems have been reported but presence or absence
of immunopathology after challenge was not reported.
The scientific advisory board also includes Douglas Cole, MD, General Partner, Flagship Ventures; Kenneth Chien, MD, Ph.D., professor in the Department of Cell and Molecular Biology and Department of Medicine at the Karolinska Institute, and visiting professor in the Department of Stem Cell and Regenerative Biology, Harvard University.; David Liu, Ph.D., Professor of Chemistry and Chemical Biology at Harvard University, a Howard Hughes Medical Institute Investigator and a Senior Associate Member of the Broad Institute of Harvard and MIT; Douglas Melton, Ph.D., Thomas Dudley Cabot Professor in the Natural Sciences at Harvard University and an Investigator of the Howard Hughes Medical Institute; Elizabeth Nabel, MD, President of the Brigham and Women's Hospital (BWH) and Professor of Medicine, Harvard Medical School; and Ulrich H. von Andrian, M.D., Mallinckrodt Professor
of Immunopathology at Harvard Medical School.
Research programs
of Immunopathology Unit aim to dissect the cellular and molecular mechanisms responsible for immunopathological responses of the liver, with emphasis on the responses that occur during infection with hepatitis B virus (HBV).
Not exact matches
Having discovered the crucial role
of IL - 27 in regulating
immunopathology, the researchers wondered whether this could be exploited for therapeutic purposes.
They found that IL - 27 levels in infected lungs follow, with some delay, the level
of virus: they peak as viral levels are starting to decline and come down when
immunopathology has resolved.
The scientists conclude that in mice «well - timed treatment with rIL - 27 improved lung injury and accelerated recovery without affecting viral clearance» and continue «these data demonstrate that IL - 27 has a unique role in controlling
immunopathology without impacting on host defense, and might therefore represent a promising candidate for immunomodulatory therapy
of viral pneumonia.»
It was a rich and rewarding workplace for a novice, surrounded by people who were experts in disparate aspects
of tuberculosis research including clinical trials, epidemiology, and
immunopathology.
Immunopathology is a branch
of medicine that deals with immune responses associated with disease.
Taking advantage
of infected patients, proprietary animal models
of infection and new technological advances in the field
of static and dynamic imaging,
Immunopathology Unit tackles unresolved issues that include the means by which innate and adaptive immune cells traffic and function within the normal, cirrhotic or cancerous livers.
Dr. Lohman - Payne's area
of research is viral
immunopathology, with special interest in the impact
of HIV exposure in...
The Department
of Medical Biotechnology consists
of many research groups covering biotechnology, vaccine development, infectious disease,
immunopathology, microbiology, genetics and microbial immunity.
Systemic perspectives on the organism and organ level address fundamental questions
of infection biology and shall contribute to reveal the molecular underpinnings
of virus - induced
immunopathologies and other inflammatory diseases.
However, challenge
of mice given any
of the vaccines led to occurrence
of Th2 - type
immunopathology suggesting hypersensitivity to SARS - CoV components was induced.
A summary
of the SARS - CoV vaccine evaluations in animal models (including the current report) that indicated an evaluation for
immunopathology after challenge is presented in Table 2.
The concern for an occurrence
of lung
immunopathology on challenge
of mice vaccinated with an inactivated virus vaccine, as reported by Haagmans, et al. for ferrets and nonhuman primates, was seen by us after challenge
of mice vaccinated with a SARS VLP vaccine [20].
That lung disease exhibited the characteristics
of a Th2 - type
immunopathology with eosinophils in the lung sections suggesting hypersensitivity that was reminiscent
of the descriptions
of the Th2 - type immunopathologic reaction in young children given an inactivated RSV vaccine and subsequently infected with naturally - occurring RSV [32]--[33].
Professor Emeritus Curtis Wilson, Jr., a world authority on the
immunopathology of kidney diseases, joined Scripps in 1968.
As indicated, two reports attributed the
immunopathology to presence
of the N protein in the vaccine; however, we found the same immunopathologic reaction in animals given S protein vaccine only, although it appeared to be
of lesser intensity.
The
immunopathology in all experiments in the present study occurred in the absence
of detectable virus in lungs
of mice two days after challenge with infectious virus.
In this regard, animal model studies with FIPV in cats and RSV in mice have indicated that viral surface proteins may be the sensitizing protein
of inactivated vaccines for
immunopathology with infection [32], [45].
As indicated, strong animal model evidence indicates expression
of the N protein by SARS - CoV vector vaccines can induce sensitization leading to a Th2 — type
immunopathology with infection.
In contrast to our results, those studies did not find clear evidence
of the Th2 type
immunopathology on challenge
of mice given a vector vaccine for the S protein.
To be certain the Th2 type
immunopathology was elicited by the S protein vaccine in our studies and in hopes a greater immune response would result from higher dosages
of the vaccine and induce greater protection against infection as well as reduce or prevent the
immunopathology, our experiment 2 used up to 9 µg
of the S protein for immunization.
Histopathology seen in animals given one
of the SARS - CoV vaccines was uniformly a Th2 - type
immunopathology with prominent eosinophil infiltration, confirmed with special eosinophil stains.
While increased titers
of serum antibody were induced and no virus was detected day two after challenge in most animals, the Th2 - type
immunopathology occurred after challenge, and the
immunopathology seen earlier after vaccination with the DI whole virus vaccine was seen again.
Using clinical samples we would like to create an immunoprofile
of activated B cells and memory B cells that may provide prognostic markers for dengue immunity and / or
immunopathology.
At Duke he also served as Director
of the Duke - VAMC Immunogenetics - Transplantation Laboratory, Director
of the Duke
Immunopathology Lab, and chief
of the Renal and Transplant Pathology services.
The Department
of Medical Biotechnologies consists
of many research groups covering biotechnology, vaccine development, infectious disease,
immunopathology, microbiology, genetics and microbial immunity.
Gastrointestinal inflammation is evident in the dogs with non-specific dietary sensitivity In collaboration with researchers at the School
of Veterinary Medicine in Hannover, Germany, and the University
of Bristol, UK, WALTHAM investigated the morphology and
immunopathology of the small and large intestine in dogs with non-specific dietary sensitivity (Zentek et al. 2002).